London Stock Exchange Notice Suspension - MGC Pharmaceuticals Limited

RNS Number : 0236J

London Stock Exchange Notice

03 April 2024

 

NOTICE

 

03/04/2024 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON MAIN MARKET - STANDARD SEGMENT

 

MGC PHARMACEUTICALS LIMITED

 

At the request of the company, trading on Main Market - Standard Segment for the under-mentioned security has been temporarily suspended from 03/04/2024 7:30am.

 

ORDINARY SHARES OF NO PAR VALUE, FULLY PAID (DI)

(BK70NQ9)

(AU000000MXC6)

 

If you have any queries relating to the above, please contact the company's broker on [phone].

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

EXCDZGGDDZGGDZM